Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Precipio, Inc. (PRPO : NSDQ)
 
 • Company Description   
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.

Number of Employees: 60

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.05 Daily Weekly Monthly
20 Day Moving Average: 8,833 shares
Shares Outstanding: 1.51 (millions)
Market Capitalization: $18.22 (millions)
Beta: 1.28
52 Week High: $12.45
52 Week Low: $3.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.59% 2.81%
12 Week 112.90% 81.84%
Year To Date 117.52% 103.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 Science Park
-
New Haven,CT 06511
USA		 ph: 203-787-7888
fax: 402-452-5401		 investors@precipiodx.com http://www.precipiodx.com
 
 • General Corporate Information   
Officers
Ilan Danieli - Chief Executive Officer
Richard Sandberg - Chairman
Matthew Gage - Chief Financial Officer
Kathleen LaPorte - Director
Ronald Andrews - Director

Peer Information
Precipio, Inc. (HLIS)
Precipio, Inc. (AZTA)
Precipio, Inc. (APYI)
Precipio, Inc. (RNVA)
Precipio, Inc. (HMSY)
Precipio, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 74019L602
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
Share - Related Items
Shares Outstanding: 1.51
Most Recent Split Date: 9.00 (0.05:1)
Beta: 1.28
Market Capitalization: $18.22 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.56
Price/Cash Flow: -
Price / Sales: 0.91
EPS Growth
vs. Year Ago Period: 59.59%
vs. Previous Quarter: -156.52%
Sales Growth
vs. Year Ago Period: 43.62%
vs. Previous Quarter: -9.56%
ROE
06/30/25 - -
03/31/25 - -25.87
12/31/24 - -35.07
ROA
06/30/25 - -
03/31/25 - -17.93
12/31/24 - -25.28
Current Ratio
06/30/25 - -
03/31/25 - 0.76
12/31/24 - 0.81
Quick Ratio
06/30/25 - -
03/31/25 - 0.57
12/31/24 - 0.64
Operating Margin
06/30/25 - -
03/31/25 - -15.45
12/31/24 - -23.15
Net Margin
06/30/25 - -
03/31/25 - -15.45
12/31/24 - -23.15
Pre-Tax Margin
06/30/25 - -
03/31/25 - -15.45
12/31/24 - -23.15
Book Value
06/30/25 - -
03/31/25 - 7.71
12/31/24 - 8.16
Inventory Turnover
06/30/25 - -
03/31/25 - 16.12
12/31/24 - 17.56
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.03
12/31/24 - 0.04
Debt-to-Capital
06/30/25 - -
03/31/25 - 3.19
12/31/24 - 3.39
 

Powered by Zacks Investment Research ©